SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-07-001313
Filing Date
2007-09-04
Accepted
2007-09-04 14:53:09
Documents
12
Period of Report
2007-08-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K lorus6k.htm 6-K 22433
2 ANTISENSE PATENT ASSETS TRANSFER AGREEMENT DATED JULY 10, 2007 ex991.htm EX-99.1 202124
3 GENESENSE SHARE PURCHASE AGREEMENT DATED JULY 10, 2007 ex992.htm EX-99.2 201126
4 NUCHEM SHARE PURCHASE AGREEMENT DATED JULY 10, 2007 ex993.htm EX-99.3 186681
5 PREPAID EXPENSES AND RECEIVABLES TRANSFER AGREEMENT DATED JULY 10, 2007 ex994.htm EX-99.4 208033
6 TANGIBLE BUSINESS ASSETS TRANSFER AGREEMENT DATED JULY 10, 2007 ex995.htm EX-99.5 264708
7 VIRULIZIN AND SMALL MOLECULE PATENT ASSETS TRANSFER AGREEMENT DATED JULY 10, 200 ex996.htm EX-99.6 206280
8 ESCROW AGREEMENT ex997.htm EX-99.7 129716
9 AMENDED AND RESTATED GENERAL SECURITY AGREEMENT ex998.htm EX-99.8 139435
10 AMENDED AND RESTATED GUARANTEE AND INDEMNITY ex999.htm EX-99.9 138854
11 INDEMINIFICATION AGREEMENT ex9910.htm EX-99.10 229099
12 EQUITY LOGO equity.jpg GRAPHIC 19897
  Complete submission text file 0001279569-07-001313.txt   1957680
Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7
Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7
LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-32001 | Film No.: 071096745
SIC: 2836 Biological Products, (No Diagnostic Substances)